Substance / Medication

Acebutolol hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

12 trials linked to this intervention

12
Total Trials
1
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
The Utility of Coronary Revascularization to Reduce Ventricular Arrhythmias in Coronary Artery Disease Patients: A Systematic Review.
Junarta Joey, Siddiqui Muhammad U, Abaza Ehab et al. · Catheter Cardiovasc Interv · 2025
PMID: 39696811Meta-Analysis
Defibrillation strategies for patients with refractory ventricular fibrillation: A systematic review and meta-analysis.
Yu Jinzhou, Yu Yanwu, Liang Huoyan et al. · Am J Emerg Med · 2024
PMID: 39127020Meta-Analysis
Efficacy of stellate ganglion block in treatment of electrical storm: a systematic review and meta-analysis.
Motazedian Pouya, Quinn Nicholas, Wells George A et al. · Sci Rep · 2024
PMID: 39433834Meta-AnalysisFull text (PMC)
Defibrillation strategies for refractory ventricular fibrillation out-of-hospital cardiac arrest: A systematic review and network meta-analysis.
Abuelazm Mohamed T, Ghanem Ahmed, Katamesh Basant E et al. · Ann Noninvasive Electrocardiol · 2023
PMID: 37482919Meta-AnalysisFull text (PMC)
Hydrogen-deuterium (H/D) exchange reaction of acebutolol hydrochloride in D₂O and CD₃OD solution.
Guesmi H, Kraim J Ben, Alatrache A et al. · Pharmazie · 2022
PMID: 36199187Other
Spectrophotometric and spectrofluorimetric methods for analysis of acyclovir and acebutolol hydrochloride.
Ayad Magda M, Abdellatef Hisham E, El-Henawee Magda M et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2007
PMID: 17035079Other
Spectrophotometric and spectrofluorimetric methods for analysis of acyclovir and acebutolol hydrochloride.
Abdellatef Hisham E, El-Henawee Magda M, El-Sayed Heba M et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2006
PMID: 16914365Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Acebutolol hydrochloride (substance)
SNOMED CT
3597005
UMLS CUI
C0543447

Clinical Data

This intervention maps to 11 entities in the Ltrl knowledge graph.

5
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
12
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.